Immunotherapy for Non-Melanoma Skin Cancer

2021
CSCC
BCC
Merkel Cell Carcinoma
Author

Sophia Z. Shalhout, Kevin S. Emerick, Howard L. Kaufman, David M. Miller

Published

August 26, 2021

Doi

https://doi.org/10.1007/s11912-021-01120-z

Abstract
We review the latest trends in cancer care for Non-Melanoma skin cancer.

Journal: Current Oncology Reports. Published Online August 27, 2021. © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021

Authors: Sophia Z. Shalhout, PhD1,2, Kevin S. Emerick,4, MD, Howard L. Kaufman, MD, PhD,3 and David Michael Miller, MD, PhD1,2

Affiliations:
1 Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Bartlett Hall, Room 132, 15 Parkman St, Boston, MA 02114, USA
2 Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Bartlett Hall, Room 132, 15 Parkman St, Boston, MA 02114, USA
3 Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
4 Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA

Reference:

Shalhout et al. (2021)

References

Shalhout, Sophia Z., Kevin S. Emerick, Howard L. Kaufman, and David M. Miller. 2021. “Immunotherapy for Non-Melanoma Skin Cancer.” Current Oncology Reports 23 (11). https://doi.org/10.1007/s11912-021-01120-z.